A comprehensive global survey commissioned by Philips has identified substantial trust disparities between healthcare professionals and patients regarding artificial intelligence implementation in medical care, with professionals showing significantly greater optimism about AI’s potential to improve patient outcomes.
Researchers have developed a novel synthetic compound called infuzide that shows promising activity against multidrug-resistant bacterial infections. The compound demonstrated effectiveness against resistant strains of Staphylococcus aureus and Enterococcus species in both laboratory and mouse studies, potentially offering a new therapeutic approach for treating serious hospital-acquired infections.
FUJIFILM Healthcare Europe has announced a formal partnership with Ibex Medical Analytics to integrate artificial intelligence-powered cancer diagnostics into digital pathology workflows, addressing the critical shortage of pathologists whilst enhancing diagnostic accuracy and efficiency.
Researchers at UC Davis have demonstrated the first brain-computer interface that directly translates neural activity into synthesised speech in real-time, allowing a man with severe ALS to communicate naturally with immediate audio feedback rather than text-based approaches.
Scientists have discovered a novel mechanism by which immune cells targeting gut bacteria can infiltrate the brain and cause neuroinflammation through molecular mimicry. The research reveals how intestinal inflammation promotes the migration of microbiota-specific T cells into the central nervous system, where they mistakenly attack brain proteins.
Researchers have discovered that theta brain waves play a crucial role in integrating visual lip movements with speech sounds during memory formation. The study demonstrates how disrupting the natural synchronisation between these audiovisual cues affects neural oscillations in both the neocortex and hippocampus, potentially impacting speech memory accuracy.
Researchers at the National University of Singapore have developed a revolutionary biomaterial that demonstrates how environmental changes around heart cells could reverse age-related cardiac damage. The breakthrough research suggests that targeting the cellular environment, rather than the cells themselves, may offer new therapeutic pathways for heart rejuvenation.
Bayer has submitted a New Drug Application to the US Food and Drug Administration for gadoquatrane, its investigational low-dose gadolinium-based contrast agent (GBCA) for contrast-enhanced magnetic resonance imaging of the central nervous system and other body regions. The submission covers use in adults and paediatric patients, including term neonates.
A landmark survey in the United States has revealed that deeply meaningful patient encounters, termed “sacred moments,” could offer a powerful antidote to the epidemic of physician burnout plaguing healthcare systems worldwide.
A revolutionary multidimensional framework for characterising acute traumatic brain injury is set to replace the outdated Glasgow Coma Scale-based classification system. The new Clinical, Biomarker, Imaging-Modifiers (CBI-M) approach integrates blood biomarkers, advanced neuroimaging, and patient-specific factors to provide clinicians with unprecedented diagnostic precision for the first 24 hours post-injury.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
UC Regents
College of Design and Engineering at NUS